newYou can now listen to Fox News articles!
US health officials confirmed Wednesday that 800,000 doses of the much-needed monkeypox vaccine will soon be available for distribution.
The announcement comes nearly two weeks after the Food and Drug Administration announced it had completed the required testing at Bavarian Nordic’s facility in Denmark, where the company is filling vials of the vaccine.
After confirming the approval was finalized, the FDA tweeted, “In light of the growing public health need, the FDA previously made a Facilitated shipment of manufactured doses to the United States.
The United States has already sent more than 310,000 doses of the Jynneos vaccine to state and local health officials. But clinics in San Francisco, New York, and other major cities say they still don’t have enough injections to meet demand.
New York City asks who to rename Monkeypox because of stigma
The Secretary of the U.S. Department of Health and Human Services said Wednesday that officials will announce additional quotas on Thursday.
The monkeypox virus is spread primarily by skin-to-skin contact, but it can also be transmitted by touching linen used by an infected person. was.
People with monkeypox may experience fever, body aches, chills, and fatigue. Many people develop acne-like bumps on their bodies.
The previously shipped dose was from another Danish facility that is already FDA-cleared. Another 786,000 doses at the newly opened Bavarian Nordic facility were awaiting US certification announced Wednesday.
The FDA requires inspection of all vaccine manufacturing plants to ensure the safety, sterility, and consistency of production.
U.S. officials announced orders for another 5 million doses this month, but most of them are not expected to arrive until next year.
CLICK HERE TO GET THE FOX NEWS APP
Officials recommend that anyone who knows or suspects they have had monkeypox in the past two weeks be vaccinated.
The Associated Press contributed to this report.